Found: 31
Select item for more details and to access through your institution.
Identification and validation of SRY-box containing gene family member <italic>SOX30</italic> methylation as a prognostic and predictive biomarker in myeloid malignancies.
- Published in:
- Clinical Epigenetics, 2018, v. 10, n. 1, p. N.PAG, doi. 10.1186/s13148-018-0523-y
- By:
- Publication type:
- Article
<italic>H19</italic> overexpression promotes leukemogenesis and predicts unfavorable prognosis in acute myeloid leukemia.
- Published in:
- Clinical Epigenetics, 2018, v. 10, n. 1, p. N.PAG, doi. 10.1186/s13148-018-0486-z
- By:
- Publication type:
- Article
Overexpression of LncRNA ITGB2-AS1 Predicts Adverse Prognosis in Acute Myeloid Leukemia.
- Published in:
- Journal of Experimental Hematology / Zhongguo Shiyan Xueyexue Zazhi, 2021, v. 29, n. 5, p. 1436, doi. 10.19746/j.cnki.issn1009-2137.2021.05.011
- By:
- Publication type:
- Article
Distinct associations of NEDD4L expression with genetic abnormalities and prognosis in acute myeloid leukemia.
- Published in:
- Cancer Cell International, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12935-021-02327-7
- By:
- Publication type:
- Article
Hypermethylation of DLX4 predicts poor clinical outcome in patients with myelodysplastic syndrome.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2016, v. 54, n. 5, p. 865, doi. 10.1515/cclm-2015-0536
- By:
- Publication type:
- Article
Hypermethylation of ITGBL1 is associated with poor prognosis in acute myeloid leukemia.
- Published in:
- Journal of Cellular Physiology, 2019, v. 234, n. 6, p. 9438, doi. 10.1002/jcp.27629
- By:
- Publication type:
- Article
SLIT2 promoter hypermethylation predicts disease progression in chronic myeloid leukemia.
- Published in:
- European Journal of Medical Research, 2022, v. 27, n. 1, p. 1, doi. 10.1186/s40001-022-00899-2
- By:
- Publication type:
- Article
Comprehensive analysis of SPAG1 expression as a prognostic and predictive biomarker in acute myeloid leukemia by integrative bioinformatics and clinical validation.
- Published in:
- BMC Medical Genomics, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s12920-022-01193-0
- By:
- Publication type:
- Article
BCL2 overexpression: clinical implication and biological insights in acute myeloid leukemia.
- Published in:
- Diagnostic Pathology, 2019, v. 14, n. 1, p. 1, doi. 10.1186/s13000-019-0841-1
- By:
- Publication type:
- Article
Abnormal expression and methylation of PRR34‐AS1 are associated with adverse outcomes in acute myeloid leukemia.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 15, p. 5283, doi. 10.1002/cam4.4085
- By:
- Publication type:
- Article
GPX3 methylation in bone marrow predicts adverse prognosis and leukemia transformation in myelodysplastic syndrome.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 1, p. 267, doi. 10.1002/cam4.984
- By:
- Publication type:
- Article
Identification and validation of prognosis‐related DLX5 methylation as an epigenetic driver in myeloid neoplasms.
- Published in:
- Clinical & Translational Medicine, 2020, v. 10, n. 2, p. 1, doi. 10.1002/ctm2.29
- By:
- Publication type:
- Article
EZH2 dysregulation: Potential biomarkers predicting prognosis and guiding treatment choice in acute myeloid leukaemia.
- Published in:
- Journal of Cellular & Molecular Medicine, 2020, v. 24, n. 2, p. 1640, doi. 10.1111/jcmm.14855
- By:
- Publication type:
- Article
Establishment and molecular characterization of decitabine‐resistant K562 cells.
- Published in:
- Journal of Cellular & Molecular Medicine, 2019, v. 23, n. 5, p. 3317, doi. 10.1111/jcmm.14221
- By:
- Publication type:
- Article
Epigenetic dysregulation of ID4 predicts disease progression and treatment outcome in myeloid malignancies.
- Published in:
- Journal of Cellular & Molecular Medicine, 2017, v. 21, n. 8, p. 1468, doi. 10.1111/jcmm.13073
- By:
- Publication type:
- Article
Dysregulation of miR-200s clusters as potential prognostic biomarkers in acute myeloid leukemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A case of Ph<sup>+</sup> acute lymphoblastic leukemia and EGFR mutant lung adenocarcinoma synchronous overlap: may one TKI drug solve two diseases?
- Published in:
- BMC Medical Genomics, 2024, v. 17, n. 1, p. 1, doi. 10.1186/s12920-024-01955-y
- By:
- Publication type:
- Article
DNA methylation-mediated differential expression of DLX4 isoforms has opposing roles in leukemogenesis.
- Published in:
- 2022
- By:
- Publication type:
- Letter
DNA methylation-mediated differential expression of DLX4 isoforms has opposing roles in leukemogenesis.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Genome-wide methylation sequencing identifies progression-related epigenetic drivers in myelodysplastic syndromes.
- Published in:
- Cell Death & Disease, 2020, v. 11, n. 11, p. 1, doi. 10.1038/s41419-020-03213-2
- By:
- Publication type:
- Article
Identification and validation of obesity-related gene LEP methylation as a prognostic indicator in patients with acute myeloid leukemia.
- Published in:
- Clinical Epigenetics, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13148-021-01013-9
- By:
- Publication type:
- Article
Decreased <italic>SCIN</italic> expression, associated with promoter methylation, is a valuable predictor for prognosis in acute myeloid leukemia.
- Published in:
- Molecular Carcinogenesis, 2018, v. 57, n. 6, p. 735, doi. 10.1002/mc.22794
- By:
- Publication type:
- Article
<italic>TET2</italic> expression is a potential prognostic and predictive biomarker in cytogenetically normal acute myeloid leukemia.
- Published in:
- Journal of Cellular Physiology, 2018, v. 233, n. 8, p. 5838, doi. 10.1002/jcp.26373
- By:
- Publication type:
- Article
Methylation‐independent CHFR expression is a potential biomarker affecting prognosis in acute myeloid leukemia.
- Published in:
- Journal of Cellular Physiology, 2018, v. 233, n. 6, p. 4707, doi. 10.1002/jcp.26253
- By:
- Publication type:
- Article
Overexpression of miR-216b: Prognostic and predictive value in acute myeloid leukemia.
- Published in:
- Journal of Cellular Physiology, 2018, v. 233, n. 4, p. 3274, doi. 10.1002/jcp.26171
- By:
- Publication type:
- Article
Hypomethylation-mediated H19 overexpression increases the risk of disease evolution through the association with BCR-ABL transcript in chronic myeloid leukemia.
- Published in:
- Journal of Cellular Physiology, 2018, v. 233, n. 3, p. 2444, doi. 10.1002/jcp.26119
- By:
- Publication type:
- Article
Overexpression of lncRNA <em>PANDAR </em>predicts adverse prognosis in acute myeloid leukemia.
- Published in:
- Cancer Management & Research, 2018, v. 10, p. 4999, doi. 10.2147/CMAR.S180150
- By:
- Publication type:
- Article
Whole-Genome DNA Methylation Sequencing Reveals Epigenetic Changes in Myelodysplastic Syndromes.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.897898
- By:
- Publication type:
- Article
SOX30 methylation correlates with disease progression in patients with chronic myeloid leukemia.
- Published in:
- OncoTargets & Therapy, 2019, v. 12, p. 4789, doi. 10.2147/OTT.S210168
- By:
- Publication type:
- Article
Increased MCL-1 expression predicts poor prognosis and disease recurrence in acute myeloid leukemia.
- Published in:
- OncoTargets & Therapy, 2019, v. 12, p. 3295, doi. 10.2147/OTT.S194549
- By:
- Publication type:
- Article
Down-regulation of miR-29c is a prognostic biomarker in acute myeloid leukemia and can reduce the sensitivity of leukemic cells to decitabine.
- Published in:
- Cancer Cell International, 2019, v. 19, n. 1, p. N.PAG, doi. 10.1186/s12935-019-0894-y
- By:
- Publication type:
- Article